I got the flu vaccine and had an anaphylactic reaction — Should I be afraid to get the Covid-19 vaccine?
When symptoms or doubts arise involving Covid-19Distinguishing between scientifically validated information and palliative care makes all the difference in the evolution of respiratory, skin, and systemic health. This page aims to deepen understanding of... "I got the flu vaccine and had an anaphylactic reaction — Should I be afraid to get the Covid-19 vaccine?", providing clear context on how the immune system reacts, which signs require medical attention, and how to structure individualized and effective care.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Anaphylactic Reaction to the Flu Vaccine and Concerns Regarding the COVID-19 Vaccine
The fear of receiving the COVID-19 vaccine after experiencing a suspected severe adverse reaction to another vaccine, such as the flu vaccine, is a frequent concern in Allergy and Immunology clinics. Individuals who report episodes of intense discomfort often face a major dilemma: the fear of a new allergic complication versus the fear of severe forms of respiratory infections, especially in more vulnerable age groups.
The first crucial step taken by the specialist physician is to differentiate a true severe systemic allergic reaction from a vasovagal response. Vasovagal reactions are relatively common and are usually triggered by anxiety, fear, or stress associated with the moment of injection. In these episodes, the patient may experience dizziness, paleness, cold sweats, and even brief loss of consciousness. However, they differ from anaphylaxis in that they do not present with widespread skin manifestations, such as urticaria and angioedema, nor obstructive respiratory or gastrointestinal involvement.
On the other hand, true anaphylaxis is characterized by an immediate hypersensitivity reaction involving multiple organs and systems. Characteristic clinical signs include the sudden appearance of reddish lesions and intense itching of the skin (urticaria), swelling of the lips or eyelids, wheezing, shortness of breath, nausea, vomiting, diarrhea, and a sharp drop in blood pressure. Confirmation that the previous adverse event was, in fact, anaphylaxis requires a rigorous medical investigation through detailed reports and clinical history.
Differences between Immunizations and Investigative Procedures
It is important to highlight that the composition of influenza and COVID-19 vaccines differs considerably. Certain components present in one vaccine—such as egg proteins in some influenza vaccines—are not necessarily present in the formulations used for COVID-19 prevention. Therefore, each patient's sensitivity profile must be evaluated individually.
When there is confirmation or strong suspicion of previous anaphylaxis to vaccines, appropriate clinical management involves referring the patient to Special Immunobiological Reference Centers (CRIE) or specialized services. At these centers, the medical team conducts a structured allergological investigation, which may include:
- Prick Test: Applying a drop of the immunizing agent directly to the skin to check for immediate hypersensitivity reactions.
- Intradermal Test: Used when the skin prick test is negative, this method involves introducing a controlled dilution of the vaccine just below the surface layer of the skin, under strict medical supervision.
If allergy tests show negative results, the vaccine can be administered in a supervised hospital or outpatient setting, keeping the patient under observation for an extended period—which may vary from one to two hours—to ensure complete safety. If the tests are positive, specific fractional desensitization protocols may be considered by specialized teams, always following the current guidelines of health authorities.
This content is strictly educational and informative in nature and should in no way replace consultation, diagnosis, and individualized medical evaluation with an Allergy and Immunology specialist.
Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema
In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.
💎 Diamond Plan — Safe immunization, even for those with a history of allergies. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Safe Immunization, Immune Response, and Protection of the Allergic Patient
Vaccine Mechanisms, Excipients, and Assessment of Immune Competence
Preventive immunization represents one of the greatest achievements of medicine in reducing hospitalizations and serious infectious complications, especially in patients with chronic respiratory diseases (such as asthma and COPD), heart disease, high blood pressure, and diabetes. Patients allergic to aeroallergens, foods, or common medications do not have a general contraindication to vaccines; allergological attention focuses on the specific evaluation of rare cases of previous anaphylaxis to isolated components of the formula (such as polyethylene glycol, polysorbate, or specific protein traces), situations that now have safe assisted application protocols.
Integration between Vaccination Schedule, Allergy Tests and Baseline Monitoring
Individualized assessment by an allergist and immunologist correlates laboratory tests of cellular and humoral immunity with the patient's actual clinical history. Combining the allergy test well indicated for preventive monitoring — including allergy vaccine In cases of atopic dermatitis, and with immunostimulant vaccines when applicable, broad, safe protection based on scientific evidence is guaranteed.
IgE-Mediated Allergy, Mixed Allergy, and Difference from Enzyme Intolerances
The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.
Mast Cell Activation, Histamine, and the Bradykinin Pathway
Urticaria is characterized by the sudden appearance of hives (intensely itchy, erythematous and edematous papules that are fleeting and disappear in less than 24 hours in the same spot without leaving a scar), and may be accompanied by angioedema in the deeper layers of the dermis and submucosa. In acute cases (lasting less than six weeks), viral infections, foods, and medications are among the classic triggers; while in chronic spontaneous urticaria or induced urticaria (dermographic, cholinergic due to sweat/heat, cold, or delayed pressure), autoimmune mechanisms or mast cell hyperreactivity play a central role.
Lower Airway Hyperreactivity and the Role of Inhalation Therapy
Objective monitoring through spirometry (pulmonary function test with bronchodilator test) is indispensable even during periods when the patient believes they are asymptomatic, as it detects silent obstructions in small airways. Modern inhaled corticosteroids act directly on the respiratory mucosa in doses measured in micrograms, offering high systemic safety, reducing severe exacerbations, and protecting respiratory capacity in the long term.
Clinical Safety Criteria and Warning Signs in Allergology
Early recognition of warning signs requiring priority medical reassessment is part of the health education of every patient and their family. Symptoms such as progressive dyspnea (difficulty breathing or speaking in complete sentences), refractory wheezing, sudden edema of the lips, tongue, or glottis, dizziness due to a drop in blood pressure, persistent fever associated with skin lesions or mucous membrane involvement require immediate emergency care, followed by a structured allergy investigation to prevent future recurrences.
Impact on Quality of Life, Sleep, and Systemic Well-being
Beyond the direct physical manifestations, uncontrolled conditions linked to Covid-19 profoundly interfere with restorative sleep patterns, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being to the individual.
Importance of Differential Diagnosis and Detailed Medical History
In the specialty of Allergy and Immunology, two patients with seemingly similar symptoms involving Covid-19 may present completely distinct pathophysiological mechanisms. For this reason, a thorough clinical history—investigating the chronology of crises, home and work environment, family history of atopy, use of concomitant medications, and dietary habits—serves as an indispensable compass for correctly interpreting laboratory tests (such as total and specific IgE levels) and functional tests. A single laboratory result can never replace in-person clinical judgment or specialized telemedicine, preventing misdiagnoses and unnecessary treatments.
Environmental Prevention, Therapeutic Adherence, and Continuous Monitoring
Long-term success in managing allergic and immunological conditions depends directly on the alliance between targeted medical treatment and daily educational measures. Maintaining well-ventilated environments free from accumulated household dust, preserving the physiological hydration of mucous membranes and the skin barrier, strictly adhering to the schedules and technique for using prescribed preventive medications, and conducting periodic check-ups allow for the stabilization of subclinical inflammation before it progresses to acute exacerbations.
Frequently Asked Questions in Clinical Practice
Immunological Reactions to Insect Bites and Prevention of Crises: Reactions triggered by arthropods are clinically divided between hypersensitivity to the saliva of hematophagous insects (such as mosquitoes, black flies, and fleas, which cause papular urticaria in childhood) and systemic allergy to the venom of hymenoptera (bees, wasps, and fire ants). While salivary antigens usually generate persistent pruritic papules and a risk of secondary bacterial infection from scratching, venom injected by a stinger can trigger massive mast cell degranulation mediated by IgE antibodies, requiring evaluation of baseline serum tryptase and an emergency action plan.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan It was designed for patients throughout Brazil who face the high cost of allergy vaccines and the difficulties of travel, offering specialized follow-up via telemedicine and easy access to immunotherapy treatment. Safe immunization, even for those with a history of allergies.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
In summary, the appropriate approach to Covid-19 This requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoid self-medication and investigate the root cause of symptoms—relying on specialized resources and reliable guidance such as... rhinitis treatment When clinically relevant, it is the safest way to manage crises, prevent complications, and ensure sustainable quality of life.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




